Viewing data from:

ELINEST

ANDA

ETHINYL ESTRADIOL; NORGESTREL | A091105 | NOVAST LABORATORIES LTD

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Elinest (2023)

Total Spending

$113K

Total Claims

3,559

Beneficiaries

705

Avg Cost/Unit

$0.63

Spending Trend

$87K(2019)→$93K(2020)→$100K(2021)→$118K(2022)→$113K(2023)

YoY Change:+1.3%

5yr CAGR:-0.6%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.03MG;0.3MG

0 patents0 exclusivities▴

TABLET;ORAL-28 | Approved: Mar 28, 2012

No patent or exclusivity listings for this strength.